menu
    • menu

    Company profile for Siolta Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic inflammatory diseases through novel microbiome-based medicines. We leverage our deep knowledge of the developing infant gut microbiome and its role in promoting immune tolerance to develop targeted microbial therapeutics and companion diagnostics for the prevention and treatment of inflammatory diseas...
    Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic inflammatory diseases through novel microbiome-based medicines. We leverage our deep knowledge of the developing infant gut microbiome and its role in promoting immune tolerance to develop targeted microbial therapeutics and companion diagnostics for the prevention and treatment of inflammatory diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Siolta TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    930 Brittan Ave. San Carlos, CA 94070
    Telephone
    Telephone
    415.991.0947
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sioltatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/siolta-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Siolta Therapeutics To Present Phase 2 ADORED Trial Results
    Siolta Therapeutics To Present Phase 2 ADORED Trial Results

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/siolta-therapeutics-announces-upcoming-late-breaking-oral-presentation-of-results-from-the-phase-2-adored-trial-at-2026-aaaai-meeting-302637419.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    Siolta Therapeutics' Microbiome Therapy Promising For Infant
    Siolta Therapeutics' Microbiome Therapy Promising For Infant

    21 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/clinical-trials/siolta-therapeutics-novel-microbiome-therapy-shows-promise-in-preventing-allergic-diseases-in-infants-18301

    INDPHARMAPOST
    21 Nov 2025
    Share Share
    Siolta Therapeutics Reports Positive Phase 2 ADORED Results
    Siolta Therapeutics Reports Positive Phase 2 ADORED Results

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/siolta-therapeutics-reports-positive-phase-2-results-from-the-adored-study-302616190.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Siolta Therapeutics and Cowellnex Enter Joint Research Agreement
    Siolta Therapeutics and Cowellnex Enter Joint Research Agreement

    29 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250129318713/en

    BUSINESSWIRE
    29 Jan 2025
    Share Share
    Nexilico And Siolta Therapeutics Collaborate To Develop Microbiome Therapeutic
    Nexilico And Siolta Therapeutics Collaborate To Develop Microbiome Therapeutic

    17 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240919057513/en

    BUSINESSWIRE
    17 Sep 2024
    Share Share
    Siolta Raises $12 Million in Series C Financing for Clinical Development
    Siolta Raises $12 Million in Series C Financing for Clinical Development

    14 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240311661886/en

    BUSINESSWIRE
    14 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search